Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Feature|Articles|October 15, 2024
Pharmacist Survey: Opportunities Abound in Direct Patient Care, AI, and Personalized Medicine
Although respondents identified some exciting areas of growth, challenges remain, including the complex insurance system and ensuring patient medication adherence.
Advertisement
Advertisement
Related to this article
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Public data may help identify drugs associated with shortages, but hospital inventory and purchasing data could make early-warning tools more useful.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Five breast cancer treatment advances in 2026 expand therapeutic options while raising questions.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
Advertisement
Advertisement